![]() AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. | ||
Founding Date | Founding Date 2001 | Founding Date 2012 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Irvine, US HQ Newport Beach, US |
Employees | Employees 811% decrease | Employees 6 |
Funding | ||
Total funding raised | Total funding raised $ 41.5m | Total funding raised $ 112.6m |

AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.
View company